These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9422091)

  • 21. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of peptides with improved affinities for anti-human chorionic gonadotropin monoclonal antibodies.
    van Amerongen A; Plasman HH; Kuperus D; Kremer L; Rodriguez-Frade JM; Albar JP; Llopis R; Schaaper WM; Meloen RH
    Pept Res; 1994; 7(2):83-90. PubMed ID: 8012125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antibody recognition of synthetic antigens from MUC1.
    Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F
    J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence.
    Schol DJ; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Murakami F; Kenemans P; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():35-45. PubMed ID: 9422087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to mucin VNTR peptides.
    Xing PX; Apostolopoulos V; Karkaloutsos J; McKenzie IF
    Methods Mol Biol; 2000; 125():369-81. PubMed ID: 10820774
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine.
    Qi W; Schultes BC; Liu D; Kuzma M; Decker W; Madiyalakan R
    Hybrid Hybridomics; 2001; 20(5-6):313-24. PubMed ID: 11839249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequences.
    Agrawal B; Reddish MA; Christian B; VanHeele A; Tang L; Koganty RR; Longenecker BM
    Cancer Res; 1998 Nov; 58(22):5151-6. PubMed ID: 9823326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues.
    Cao Y; Karsten U; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():88-99. PubMed ID: 9422093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of hydropathic complementarity for the binding of the neuropeptide substance P to a monoclonal antibody: equilibrium and kinetic studies.
    Hanin V; Déry O; Boquet D; Sagot MA; Créminon C; Couraud JY; Grassi J
    Mol Immunol; 1997; 34(12-13):829-38. PubMed ID: 9464518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
    Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
    Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the antigenic peptide transporter TAP by recombinant antibodies binding to the last five residues of TAP1.
    Plewnia G; Schulze K; Hunte C; Tampé R; Koch J
    J Mol Biol; 2007 May; 369(1):95-107. PubMed ID: 17418234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antipeptide antibodies: affinity and kinetic rate constants measured for the peptide and the cognate protein using a biosensor technology.
    Zeder-Lutz G; Altschuh D; Geysen HM; Trifilieff E; Sommermeyer G; Van Regenmortel MH
    Mol Immunol; 1993 Feb; 30(2):145-55. PubMed ID: 7679185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1.
    Pericleous LM; Richards J; Epenetos AA; Courtenay-Luck N; Deonarain MP
    Br J Cancer; 2005 Nov; 93(11):1257-66. PubMed ID: 16265351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
    Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
    Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity clusters of MUC1-reactive mouse monoclonal antibodies.
    Hanisch FG
    Tumour Biol; 1998; 19 Suppl 1():111-7. PubMed ID: 9422095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity.
    Mazor Y; Keydar I; Benhar I
    Mol Immunol; 2005 Jan; 42(1):55-69. PubMed ID: 15488944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
    Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
    J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.